Systematic in Vitro Evolution in Reveals Key Determinants of Drug Resistance

Surveillance of drug resistance and the discovery of novel targets-key objectives in the fight against malaria-rely on identifying resistance-conferring mutations in parasites. Current approaches, while successful, require laborious experimentation or large sample sizes. To elucidate shared determinants of antimalarial resistance that can empower in silico inference, we examined the genomes of 724 clones, each selected in vitro for resistance to one of 118 compounds. We identified 1448 variants in 128 recurrently mutated genes, including drivers of antimalarial multidrug resistance. In contrast to naturally occurring variants, those selected in vitro are more likely to be missense or frameshift, involve bulky substitutions, and occur in conserved, ordered protein domains. Collectively, our dataset reveals mutation features that predict drug resistance in eukaryotic pathogens.

Citing Articles

Heterogeneous constraint and adaptation across the malaria parasite life cycle.

Perkins S, Neafsey D, Early A bioRxiv. 2025; .

PMID: 39990389 PMC: 11844417. DOI: 10.1101/2025.02.11.636054.

Predicting Plasmodium drug resistance through in vitro evolution.

Cui L Trends Parasitol. 2025; 41(3):170-171.

PMID: 39933988 PMC: 11884984. DOI: 10.1016/j.pt.2025.01.008.

Stereospecific Resistance to N2-Acyl Tetrahydro-β-carboline Antimalarials Is Mediated by a PfMDR1 Mutation That Confers Collateral Drug Sensitivity.

Bremers E, Butler J, Do Amaral L, Merino E, Almolhim H, Zhou B ACS Infect Dis. 2025; 11(2):529-542.

PMID: 39808111 PMC: 11828674. DOI: 10.1021/acsinfecdis.4c01001.

Replication stress increases de novo CNVs across the malaria parasite genome.

Brown N, Luniewski A, Yu X, Warthan M, Liu S, Zulawinska J bioRxiv. 2025; .

PMID: 39803504 PMC: 11722320. DOI: 10.1101/2024.12.19.629492.

References

Baragana B, Hallyburton I, Lee M, Norcross N, Grimaldi R, Otto T . A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature. 2015; 522(7556):315-20. PMC: 4700930. DOI: 10.1038/nature14451. View

Hamid M, Abdelraheem M, Acheampong D, Ahouidi A, Ali M, Almagro-Garcia J . Pf7: an open dataset of genome variation in 20,000 worldwide samples. Wellcome Open Res. 2023; 8:22. PMC: 9971654. DOI: 10.12688/wellcomeopenres.18681.1. View

Valderramos S, Valderramos J, Musset L, Purcell L, Mercereau-Puijalon O, Legrand E . Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum. PLoS Pathog. 2010; 6(5):e1000887. PMC: 2869323. DOI: 10.1371/journal.ppat.1000887. View

Kumpornsin K, Kochakarn T, Yeo T, Okombo J, Luth M, Hoshizaki J . Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum. Nat Commun. 2023; 14(1):3059. PMC: 10224993. DOI: 10.1038/s41467-023-38774-1. View

Ke H, Ganesan S, Dass S, Morrisey J, Pou S, Nilsen A . Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages. PLoS One. 2019; 14(4):e0214023. PMC: 6456166. DOI: 10.1371/journal.pone.0214023. View

Davies H, Belda H, Broncel M, Ye X, Bisson C, Introini V . An exported kinase family mediates species-specific erythrocyte remodelling and virulence in human malaria. Nat Microbiol. 2020; 5(6):848-863. PMC: 7116245. DOI: 10.1038/s41564-020-0702-4. View

Lee A, Fidock D . Evidence of a Mild Mutator Phenotype in Cambodian Plasmodium falciparum Malaria Parasites. PLoS One. 2016; 11(4):e0154166. PMC: 4839739. DOI: 10.1371/journal.pone.0154166. View

Miles A, Iqbal Z, Vauterin P, Pearson R, Campino S, Theron M . Indels, structural variation, and recombination drive genomic diversity in Plasmodium falciparum. Genome Res. 2016; 26(9):1288-99. PMC: 5052046. DOI: 10.1101/gr.203711.115. View

Fisher G, Cobbold S, Jezewski A, Carpenter E, Arnold M, Cowell A . The Key Glycolytic Enzyme Phosphofructokinase Is Involved in Resistance to Antiplasmodial Glycosides. mBio. 2020; 11(6). PMC: 7733947. DOI: 10.1128/mBio.02842-20. View

10.

Josling G, Russell T, Venezia J, Orchard L, van Biljon R, Painter H . Dissecting the role of PfAP2-G in malaria gametocytogenesis. Nat Commun. 2020; 11(1):1503. PMC: 7083873. DOI: 10.1038/s41467-020-15026-0. View

11.

Kreutzfeld O, Rasmussen S, Ramanathan A, Tumwebaze P, Byaruhanga O, Katairo T . Associations between Varied Susceptibilities to PfATP4 Inhibitors and Genotypes in Ugandan Plasmodium falciparum Isolates. Antimicrob Agents Chemother. 2021; 65(10):e0077121. PMC: 8448140. DOI: 10.1128/AAC.00771-21. View

12.

Rausch T, Zichner T, Schlattl A, Stutz A, Benes V, Korbel J . DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics. 2012; 28(18):i333-i339. PMC: 3436805. DOI: 10.1093/bioinformatics/bts378. View

13.

Siqueira-Neto J, Wicht K, Chibale K, Burrows J, Fidock D, Winzeler E . Antimalarial drug discovery: progress and approaches. Nat Rev Drug Discov. 2023; 22(10):807-826. PMC: 10543600. DOI: 10.1038/s41573-023-00772-9. View

14.

Veiga M, Dhingra S, Henrich P, Straimer J, Gnadig N, Uhlemann A . Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016; 7:11553. PMC: 4873939. DOI: 10.1038/ncomms11553. View

15.

Meister S, Plouffe D, Kuhen K, Bonamy G, Wu T, Barnes S . Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science. 2011; 334(6061):1372-7. PMC: 3473092. DOI: 10.1126/science.1211936. View

16.

Park D, Lukens A, Neafsey D, Schaffner S, Chang H, Valim C . Sequence-based association and selection scans identify drug resistance loci in the Plasmodium falciparum malaria parasite. Proc Natl Acad Sci U S A. 2012; 109(32):13052-7. PMC: 3420184. DOI: 10.1073/pnas.1210585109. View

17.

Rocamora F, Zhu L, Liong K, Dondorp A, Miotto O, Mok S . Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites. PLoS Pathog. 2018; 14(3):e1006930. PMC: 5868857. DOI: 10.1371/journal.ppat.1006930. View

18.

Pelleau S, Moss E, Dhingra S, Volney B, Casteras J, Gabryszewski S . Adaptive evolution of malaria parasites in French Guiana: Reversal of chloroquine resistance by acquisition of a mutation in pfcrt. Proc Natl Acad Sci U S A. 2015; 112(37):11672-7. PMC: 4577156. DOI: 10.1073/pnas.1507142112. View

19.

Jimenez-Diaz M, Ebert D, Salinas Y, Pradhan A, Lehane A, Myrand-Lapierre M . (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium. Proc Natl Acad Sci U S A. 2014; 111(50):E5455-62. PMC: 4273362. DOI: 10.1073/pnas.1414221111. View

20.

Timmann C, Thye T, Vens M, Evans J, May J, Ehmen C . Genome-wide association study indicates two novel resistance loci for severe malaria. Nature. 2012; 489(7416):443-6. DOI: 10.1038/nature11334. View